22nd Century Group (22nd Century Group) Risk Assessment

View and export this data going back to 2011. Start your Free Trial

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of 22nd Century Group is: High Risk: High uncertainty.

Competitive Comparison

For the Tobacco subindustry, 22nd Century Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

22nd Century Group Risk Assessment Distribution

For the Tobacco Products industry and Consumer Defensive sector, 22nd Century Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where 22nd Century Group's Risk Assessment falls into.

22nd Century Group (NAS:XXII) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

22nd Century Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

22nd Century Group (22nd Century Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204

Website

https://www.xxiicentury.com

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.

Executives

Andrew Arno	director	C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish	director, officer: Chief Executive Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino	officer: Chief Administrative Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola	officer: Chief Legal Officer	BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller	officer: President, Tobacco	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany	director	C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher	officer: Chief Operating Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman	officer: Chief Financial Officer	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald	officer: Chief Financial Officer	C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson	director	C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders	director	1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien	director	C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov	director	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan	director	C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203